Qu Tian: From *The Art of War* to the Mindset of Going Global | Late 2025
It was never a sprint.
Articles
After OpenClaw Went Viral, More Startup Signals We're Tracking (Part 2)
The day before yesterday, we published an article titled *[After OpenClaw Went Viral, Here Are the Startup Signals We Spotted](https://mp.weixin.qq.com/s?__biz=MzAxMDMxOTI2NA==&mid=2649104427&idx=1&sn=7c8af0436828d775a9c7e2501c9a70dc&)*
A Conversation with Sam Guo: Staying Out of the Fray, but Keeping on Winning
Truck drivers, sour kiwis, counterfeit cigarettes and booze — and the legends of investing.
BlueRun Ventures Continues Backing, Angel-Stage Project Yangshan Medical Completes Pre-A Round | BlueRun Portfolio
"Medical-Engineering Integration" for Better Assistance
After OpenClaw Went Viral, Here Are the Startup Signals We're Seeing
What entrepreneurial directions does it open up?
I Handed a Departing Colleague's Mess to a Domestic Agent
On the desktop agent front, Kunlun Tech's Skywork has delivered a new specimen.
Qiming Venture Partners Portfolio Company Northmed Technology Debuts on STAR Market
In 2020, Qiming Venture Partners led the Series C round for NorthSea Therapeutics and continued to support the company's growth in its Series D round.
Qiming Venture Partners' Zhang Ao: Six Years with NorthMed, Strong Confidence in China Healthcare Innovation Fundamentals
From Qiming Venture Partners' perspective, an increasing number of Chinese medical innovations are demonstrating internationally leading clinical value, and their global competitiveness is rapidly rising.
We now have an Agent on Moltbook.
Let the Token Fly a Little Longer
The Business Code Behind Zocdoc's IPO: Building China's Costco of Healthcare Services
Finding the "Care" in Healthcare.